Search RHCG Website
Select your language

Booster immunisation of patients treated with standard dose chemotherapy

What's New

Guideline previously titled: Booster immunisation of patients treated for leukaemia, Hodgkin’s Disease, a solid tumour, or recipients of an autologous stem cell transplant

1. Introduction

The administration of booster immunisations should be started no earlier than 6 months after completion of chemotherapy treatment for leukaemia, lymphoma or solid tumour.

Children treated with High Dose Chemotherapy, followed by Autologous or Allogeneic Haematopoietic Stem Cell Transplant (HSCT) will receive a comprehensive revaccination programme at 12 months post transplant, which reflects their more profound immune suppression.

Important Note: the current unit policy is not to measure functional antibody status in children after completion of standard dose chemotherapy.

3. Authorised personnel/specific staff competencies

Health & Social Care Partnership (HSCP) staff, in liaison with Primary Care, will be responsible for administering immunisations.  All requests for NHSGGC patient immunisation should be sent to the Screening Department, Templeton Business Centre, First Floor Building 2, 62 Templeton Street, Glasgow G40 1DA. 

Those residing outwith NHSGGC this should be sent to the appropriate HSCP.

4. Equipment/materials

Not applicable

5. Procedure

Each patient’s consultant will decide if booster immunisations are required and when these should start. 

Appendix 1 shows the correct vaccination details and will be completed and copied to the patient’s GP and the relevant HSCP.

Further information/exceptions

For further information contact:  On-call Consultant via Switchboard

Appendix 1: GP letter for patients treated with standard dose chemotherapy
Editorial Information

Last reviewed: 31 January 2021

Next review: 31 January 2023

Author(s): Dr A M Ewins

Version: 4

Approved By: Sch Clin Gov Group & Virology

Document Id: RHC-HAEM-ONC-027